Does post-cardiac surgery magnesium supplementation improve outcome?

Area of Science:

• Cardiology
• Intensive Care Medicine
• Nephrology

Background:

• Hypomagnesemia is associated with increased morbidity and mortality in critically ill patients.
• Hypomagnesemia is a common complication following cardiopulmonary bypass surgery.

Purpose of the Study:

• To evaluate the efficacy of magnesium supplementation in the immediate postoperative period for patients undergoing cardiac surgery with cardiopulmonary bypass.
• To determine if magnesium administration can improve clinical outcomes in this patient population.

Main Methods:

• Prospective, randomized, double-blind, placebo-controlled study.
• 216 patients undergoing elective cardiac surgery with cardiopulmonary bypass were randomized.
• Treatment group received intravenous magnesium sulfate; control group received placebo.

Main Results:

• No significant differences observed in primary endpoint (hours of intubation) or secondary endpoints (inotropic support, arrhythmias, ICU stay, mortality).
• 12% of patients had hypomagnesemia on ICU admission.
• The magnesium group showed an increased need for pacemaker stimulation.

Conclusions:

• Magnesium supplementation administered post-cardiac surgery with cardiopulmonary bypass did not demonstrate favorable effects on clinical outcomes.
• Further research may be needed to explore specific patient subgroups or alternative magnesium administration protocols.